BA Study of IMP4297 (20mg vs 10mg) in Healthy Male Subjects

Summary

An open-label, randomized, single-dose, 2-way crossover study to compare the bioavailability of two IMP4297 formulations (20 mg capsules and 10 mg capsules) after single oral administration of 100 mg IMP4297 under fasted condition in healthy male subjects

Timeline

Start

2020-10-29

Primary completion

2021-02-11

Completion

2021-04-30

Drugs

Indications